Correction to: Changes in Cataplexy Frequency in a Clinical Trial of Lower‑Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications (CNS Drugs, (2022), 36, 6, (633-647), 10.1007/s40263-022-00926-0)

The article “Changes in Cataplexy Frequency in a Clinical Trial of Lower‑Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications”, written by Yves Dauvilliers, Karel Šonka, Richard K. Bogan, Markku Partinen, Rafael Del Rio Villegas, Nancy Foldvary‑Schaefer, Roman Skowronski, Abby Chen, Jed Black, Franck Skobieranda, Michael J. Thorpy was originally published Online First without Open Access. After publication in volume 36, issue 6, page 633–647 the author decided to opt for Open Choice and to make the article an Open Access publication. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 21 June 2022 to The Author(s) 2022 and the article is forthwith distributed under a Creative Commons Attribution NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-​nc/4.0/. The original article has been corrected.